Verifying the Effectiveness of the NUsurface® System
Public ClinicalTrials.gov record NCT02108496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System) A Multi-centered, Prospective, Randomized, Interventional, Superiority Clinical Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The NUsurface® Meniscus Implant Randomized Study is a multi-center, prospective randomized, interventional clinical trial to test the hypothesis that the NUsurface implant is superior to the non-surgical standard of care in treating the target population.The rationale for performing this clinical study is to gather clinical data to evaluate the safety and effectiveness of the NUsurface device compared to the Standard of Care.
Study identification
- NCT ID
- NCT02108496
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 337 participants
Conditions and interventions
Conditions
Interventions
- NUsurface® Meniscus Implant Device
- NSAID's and Non-surgical Treatment Options Drug
- Intra-Articular Injections with Corticosteroids Drug
- Intra-Articular Injections with Hyaluronic Acid (HA) Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 30 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2014
- Primary completion
- May 31, 2021
- Completion
- May 2, 2022
- Last update posted
- Jul 27, 2026
2014 – 2022
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| OrthoIndy | Indianapolis | Indiana | 46143 | — |
| Brigham and Woman's Hospital | Boston | Massachusetts | 02115 | — |
| New England Baptist Hospital | Roxbury Crossing | Massachusetts | 02120 | — |
| Capital Region Orthopaedics | Albany | New York | 12206 | — |
| Lenox Hill Hospital | New York | New York | 10075 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43221 | — |
| OrthoSouth | Memphis | Tennessee | 38120 | — |
| Advanced Orthopaedics | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02108496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02108496 live on ClinicalTrials.gov.